Many studies have indicated a significant association between high cyclin D1 expression and clinical outcome of patients not only in HSC but also several other types of cancers such as lung cancer, pancreatic cancer, breast cancer, melanoma and multiple myeloma. Here, CCND1 is linked to melanoma.